According to Advaxis's latest financial reports the company's current earnings (TTM) are -$34.03 M. In 2021 the company made an earning of -$39.22 M a decrease over its 2020 earnings that were of -$29.78 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$33.55 M | |
2021 | -$39.22 M | 31.71% |
2020 | -$29.78 M | 68.13% |
2019 | -$17.72 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | -$37.2 M | 9.31% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | -$0.14 B | 293.54% | ๐บ๐ธ USA |
Heska Corporation
HSKA | -$18.34 M | -46.11% | ๐บ๐ธ USA |